Search - tctmd.com

Displaying 861 - 880 of 922

Sort: Relevancy | Date

News Daily News

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

July 03, 2012

News Daily News

Meta Análisis: La Estrategia Invasiva Precoz es la Mejor en Pacientes Diabéticos con SCASEST

July 03, 2012

News Daily News

La Enfermedad Polivascular Empeora el Pronóstico a Largo Plazo de Pacientes NSTEMI

July 03, 2012

Presentation

Polyvascular Disease and Long-term Cardiovascular Outcomes in Older Patients with NSTEMI

Presenter: S. Subherwal

July 02, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Industry News

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

June 21, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

Presentation

Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients

Presenter: Dirk Sibbing

June 06, 2012

News Daily News

Un Registro Confirma un Descenso Generalizado de las Hemorragias Post-PCI pero no en los casos de STEMI

Caitlin E. Cox

June 01, 2012

News Daily News

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

Caitlin E. Cox

June 01, 2012

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

Presentation Fellows 2012

Management of Unstable Angina and NSTEMI: Guidelines, Clinical Studies, and Real-World Performance

Presenter: George Dangas

April 21, 2012

News Conference News ACC 2012

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

L.A. McKeown

March 25, 2012

Presentation PCI Outcomes 2012

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Presenter: C. Michael Gibson

March 23, 2012

News Daily News

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

Caitlin E. Cox

March 20, 2012

News Daily News

Relación Hemorragia Intrahospitalaria/Mortalidad tras Sufrir un NSTEMI

Caitlin E. Cox

March 12, 2012

Advertisement

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

Meta Análisis: La Estrategia Invasiva Precoz es la Mejor en Pacientes Diabéticos con SCASEST

La Enfermedad Polivascular Empeora el Pronóstico a Largo Plazo de Pacientes NSTEMI

Polyvascular Disease and Long-term Cardiovascular Outcomes in Older Patients with NSTEMI

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Prognostic Value of High On-Clopidogrel Platelet Reactivity in Bivalirudin- vs. Abciximab-Treated NSTEMI Patients

Un Registro Confirma un Descenso Generalizado de las Hemorragias Post-PCI pero no en los casos de STEMI

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Management of Unstable Angina and NSTEMI: Guidelines, Clinical Studies, and Real-World Performance

Color Coding, Checklists Improve Use of Evidence-Based Strategies for ACS

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI

Relación Hemorragia Intrahospitalaria/Mortalidad tras Sufrir un NSTEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content